- Trump biopic hits Cannes Film Festival
- Iran President Raisi's helicopter found, 'no sign of life'
- Three talking points ahead of 2024 French Open
- 'Haikyu!!': Comic heroes fuel Japan Olympic volleyball manga mania
- Timberwolves rally to knock defending champion Nuggets out of NBA playoffs
- London court set to rule on Julian Assange extradition
- Business and Bollywood votes in India election
- Pope calls anti-migrant attitudes at US border 'madness'
- Mexico aims to be big economic winner from US-China tensions
- Uncertain future for thousands after deadly Brazil floods
- Schauffele makes the putt of his life for first major win
- Wirtz returns to help unbeaten Leverkusen chase history
- Search for Iran's President Raisi after helicopter goes missing
- DeChambeau's powerful putting has him excited for US Open
- Taiwan to swear in new president as China pressure grows
- Atalanta can end 61-year wait for trophy in Europa League final
- Schauffele birdies final hole to capture PGA for first major win
- Guardiola casts doubt over long-term Man City future
- Hollywood icons Costner and Demi Moore make Cannes comeback
- Pacers shoot down Knicks to reach NBA Eastern Conference finals
- Schauffele birdies final hole, captures first major at PGA Championship
- McLaughlin powers to Indy 500 pole in all-Penske front row
- Monaco footballer tapes over LGBTQ badge
- Korda wins sixth LPGA title of year with win at Liberty National
- Pacers put on shooting show to down Knicks, reach NBA Eastern Conference finals
- US envoy touts 'potential' of Israel-Saudi deal in Netanyahu talks
- Dominicans vote for president in poll overshadowed by Haiti crisis
- Brest secure Champions League qualification, PSG win without Mbappe
- Mbappe absent as PSG win final Ligue 1 game
- Still exhausted after arrest, Scheffler closes with 64 at PGA
- Brest secure historic Champions League qualification
- France's Macron calls fresh emergency on New Caledonia unrest
- Taiwan swears in new president as China pressure grows
- Schauffele leads as dramatic PGA back-nine battle begins
- Biden faces silent Gaza protest at Martin Luther King Jr's college
- Ten Hag says Man Utd 'must do everything' to win FA Cup after Premier League flop
- Cannes film follows Egypt feminists on brink of adulthood
- Pep Guardiola: Man City manager addicted to winning
- Jackson wins season opener in Marrakesh with all eyes on Paris
- Things get real as imaginary friend flick 'If' tops N.America box office
- Paris seeks to boost sluggish sales for Paralympic Games
- How a French director pulled off Cannes's crazy Mexican narcos hit
- Man City make case to be ranked as England's greatest-ever team
- Hamdy gives Zamalek second CAF Confederation Cup title
- Rome champion Zverev eyes French Open but wary of Djokovic 'at his best'
- Spain recalls its ambassador to Argentina over 'insult'
- Real Sociedad reach Europa League, Cadiz relegated
- Man City's six Premier League titles in seven years 'insane': Guardiola
- Dramatic last-round showdown under way at PGA Championship
- It may take 100 points to stop Man City, says Arsenal boss Arteta
US govt sends drugmakers initial offers in price talks
The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.
The move comes as President Joe Biden pushes to rein in health care costs ahead of November's election.
The negotiation program came on the back of Biden's landmark Inflation Reduction Act, a major package of energy transition policy and social reforms.
This allowed Medicare, the federal health insurance for seniors, to start negotiating drug costs -- a first in its nearly 60-year existence.
"This is the first time ever that Medicare is not accepting the drug prices the pharmaceutical companies set," the White House said in a statement on Thursday.
It did not reveal how much it offered for each drug.
A Johnson & Johnson spokesperson told AFP the company has received an initial price from the government but said it was "respecting the confidential nature of the process."
Last October, major drugmakers behind 10 selected medicines for serious illnesses grudgingly agreed to negotiate on cutting prices.
But pharmaceutical companies have pushed back against the initiative, earlier saying that they came on board as they had no choice.
While the US government is initially limited to picking 10 drugs for price talks, it can expand the program in subsequent years.
The drugs include Farxiga by AstraZeneca used against diabetes, Entresto by Novartis to treat heart failure, as well as anticoagulant Eliquis -- used by millions of Medicare beneficiaries.
According to the White House, nine million seniors on Medicare were prescribed the 10 drugs in 2022, spending some $3.4 billion out-of-pocket that year.
The statement also took aim at Big Pharma, which the White House said "charged Americans two to three times more" than in other countries, even when accounting for rebates and discounts.
Biden, who is campaigning for reelection with a large focus on easing voters' financial burdens, said in a separate statement: "My Administration won't stop fighting to lower health care costs for seniors and families."
New negotiated prices for the 10 prescription drugs are set to be announced later this year.
Medicare is expected to negotiate prices for up to 60 drugs over the next four years, and up to an additional 20 drugs each year after that.
Several companies have taken legal action challenging the provisions.
S.Keller--BTB